Do Endocrine Disrupting Chemicals (EDCs) Increase Testicular Cancer Risk? Dr. Anthony Corcoran, MD
AI Vs. Drug ResistanceПодробнее
Risk Factors for Testicular CancerПодробнее
New Clinical Genetic Model Better Predicts Survival for Men with mCRPC | ASCO 2024Подробнее
Testicular Cancer Awareness - Risks, Prevention, and TreatmentПодробнее
Testicular CancerПодробнее
Researchers Identify Best Drug Therapy for Rare, Aggressive, Pancreatic CancerПодробнее
Who is at Risk for Testicular Cancer?Подробнее
Male Reproductive Health Crisis: Endocrine Disrupting Chemicals and Racial InequitiesПодробнее
Risk Factors for Testicular CancerПодробнее
Dr. Christopher Barbieri - Testicular Cancer Awareness (Risk Factors & Screening)Подробнее
Smith Polygenic Risk Test- For DoctorsПодробнее
The Benefits of ASCO's TAPUR TrialПодробнее
Discovery of Targets for Bipotent Anticancer DrugПодробнее
Why your oncologist might resist ordering genetic testing for youПодробнее
The Strength of Endocrine DisruptorsПодробнее
Chemotherapy for testicular cancer patients with 'intermediate risk'Подробнее
Testicular CancerПодробнее
How Does Testicular Cancer Treatment Affect Fertility? | Dana-Farber Cancer InstituteПодробнее
